QA review – Page 12 – Pharma.Tips

Unapproved retest workflows in LIMS test assignment workflows: Data Integrity Risks and Corrective Controls

Managing Unapproved Retest Workflows in LIMS: Ensuring Data Integrity Within the pharmaceutical industry, compliance with regulatory standards is non-negotiable. One of the critical challenges faced by organizations is maintaining LIMS…

Uncontrolled Processing Methods: Root Causes, GMP Risks, and CAPA Controls

Addressing Uncontrolled Processing Methods: Navigating Root Causes and GMP Implications In the pharmaceutical industry, maintaining the integrity of data generated by analytical systems like chromatography data systems (CDS) is paramount.…

Unapproved retest workflows in LIMS sample login and accessioning: Data Integrity Risks and Corrective Controls

Addressing Unapproved Retest Workflows in LIMS: Essential Controls for Data Integrity In the realm of pharmaceutical manufacturing and quality control, LIMS (Laboratory Information Management Systems) play a crucial role in…

How to Prevent Sequence Deletion and Sample Omission in CDS (Chromatography Data System) Risks

Mitigating Risks of Sequence Deletion and Sample Omission in Chromatography Data Systems In pharmaceutical manufacturing, safeguarding data integrity is paramount, particularly within Chromatography Data Systems (CDS). One prevalent issue is…

Manual result override risks in LIMS stability sample pulls: Data Integrity Risks and Corrective Controls

Addressing Risks of Manual Result Overrides in LIMS Stability Sample Pulls In modern pharmaceutical manufacturing, Laboratory Information Management Systems (LIMS) play a crucial role in ensuring data integrity and compliance.…

Step-by-Step Guide to Managing Reprocessing Without Scientific Justification Under ALCOA+ Expectations

Effective Management of Reprocessing Within ALCOA+ Expectations for CDS Data Integrity In pharmaceutical manufacturing, maintaining data integrity within Chromatography Data Systems (CDS) is critical to ensure compliance and uphold product…

Manual result override risks in LIMS specification management: Data Integrity Risks and Corrective Controls

Managing Risks in LIMS Specification Management: A Case Study on Data Integrity Challenges In the ever-evolving landscape of pharmaceutical manufacturing, the importance of laboratory information management systems (LIMS) cannot be…

Why Method Version Drift Happens and How QA Teams Should Control It

Addressing Method Version Drift in Chromatography: A Guide for QA Teams The pharmaceutical industry is perpetually challenged by various data integrity risks, particularly those associated with chromatography data systems (CDS).…

Manual result override risks in LIMS sample login and accessioning: Data Integrity Risks and Corrective Controls

Addressing LIMS Data Integrity Issues in Sample Login and Accessioning In today’s pharmaceutical environment, the integrity of laboratory data is imperative for compliance and quality assurance. One significant concern arises…

Inspection-Ready Approach to Shared Administrator Accounts in Pharmaceutical Operations

Managing Data Integrity Risks Associated with Shared Administrator Accounts in Pharmaceutical Operations The increasing reliance on digital systems within pharmaceutical manufacturing has created significant challenges regarding data integrity, particularly related…

Uncontrolled specification changes in LIMS stability sample pulls: Data Integrity Risks and Corrective Controls

Managing Uncontrolled Specification Changes in LIMS for Stability Sample Pulls In the realm of pharmaceutical manufacturing, data integrity issues often pose significant risks, particularly in the context of Laboratory Information…

Missing Audit Trail Review: Root Causes, GMP Risks, and CAPA Controls

Addressing Missing Audit Trail Reviews in CDS: Root Causes, Risks, and Corrective Solutions In the realm of pharmaceutical manufacturing, maintaining the integrity of data is pivotal, particularly when it comes…